Manny Villafaña, Chairman and Chief Executive Officer of Kips Bay Medical, Inc. (NASDAQ: KIPS) announced the addition of two new officers to the Company’s management team and the departure of one officer.
On May 2, 2011, Mr. Michael Reinhardt will join the Company as its Vice President of Sales & Marketing. Mr. Reinhardt has thirty years of sales and marketing experience. Mr. Reinhardt’s recent experience includes serving as Vice President of Global Marketing of ATS Medical, Inc., a provider of heart valves and life-saving cardiac surgery products and Vice President of Global Marketing for the Cardiac Surgery Division of St Jude Medical, Inc. Mr. Reinhardt holds a Master of Business Administration in general business from Baruch College, New York, NY and a Bachelor of Business Administration in Marketing from Ohio University, Athens, OH.
On May 16, 2011, Mr. Randall K. LaBounty will join the Company as its Vice President of Regulatory and Clinical Affairs. Mr. LaBounty has over twenty years of experience working in medical research with sixteen years of experience in cardiovascular medical devices. Prior to joining the Company, Mr. LaBounty served as Vice President of Clinical Research of Osprey Medical and as the Vice President of Clinical and Regulatory Affairs for Lumen Biomedical, Inc. Mr. LaBounty holds a Master of Science in Biostatistics and a Bachelor of Science in Genetics and Cell Biology from the University of Minnesota.
Michael P. Winegar, Vice President of Regulatory Affairs, Chief Operating Officer, and Director of Kips Bay Medical, Inc. (the “Company”), recently notified the Company of his intention to retire from his position as an executive officer and employee of the Company. Mr. Winegar will remain with the Company in his current position for a period of time to participate in the transition and training of the Company’s new Vice President of Regulatory and Clinical Affairs and has agreed to provide assistance to the Company and our Board of Directors on a consulting basis after his final separation from employment. Mr. Villafaña will assume responsibility for oversight of the operations of the Company upon Mr. Winegar’s departure. Mr. Winegar will not be nominated for re-election as a Director at the Company’s 2011 Annual Meeting of Stockholders, and will remain as a Director of the Company until such meeting.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV